What to look forward to in GaBI Journal, 2017, Issue 2

Author(s): Professor Philip D Walson, MD

The use both generics and biosimilars offers the potential to increase availability of medicines through decreases in cost that should occur when an expensive product (drug) loses patent protection and lower cost alternatives are marketed in countries with a ‘free-market’ economy. As the manuscripts in this issue of GaBI Journal emphasize, it is clear however […]

Read more →